How the CDC's Epidemic Intelligence Service protects public health at home and abroad
When the Trump administration announced in February 2025 that it was cutting 10% of staff at the Centers for Disease Control and Prevention, it seemed that a small but storied program within it called the Epidemic Intelligence Service – also known as the CDC's disease detectives – would also be cut. A few days later, the program was reinstated. And in March, Epidemic Intelligence Service officers traveled to Texas to support the state's public health officials in fighting the ongoing measles epidemic.
But after another massive upheaval at the CDC in April, the unit's future is uncertain. As of now, applications for the program's next round of fellows has been postponed.
The Epidemic Intelligence Service is a dynamic crisis response team. Just as firefighters rush into burning buildings to save lives, this team's specialists mobilize both domestically and internationally to help curb disease outbreaks. But first and foremost, it is a training program that has produced some of the most highly trained and regarded public health experts in the country who have gone on to work at local and state public health offices, academic departments and international health organizations.
We are public health experts – one an experienced professor who served in the Epidemic Intelligence Service from 1994-1996, and the other an early career trainee who was accepted to its incoming class of 2025-2027. Although it's not clear how the administration will enact its new vision for the CDC, we hope a continued urgency to identify and fight infectious disease threats – the essence of the Epidemic Intelligence Service – remains a national priority.
The Epidemic Intelligence Service is a two-year fellowship open to physicians, scientists and other health professionals. The program accepts 50 to 80 people each year.
The Epidemic Intelligence Service was founded in 1951, just five years after the launch of the CDC, in response to Cold War-era concerns about biological warfare. Alexander Langmuir, its founder, was the CDC's chief epidemiologist and has often been called the father of shoe-leather epidemiology – on-the-ground, out-of-the-office disease investigation through extensive field work and engagement with affected populations.
In a report announcing the unit's establishment, Langmuir and a colleague wrote that one of the 'problems that would emerge in the event of biological warfare attacks' was 'the dearth of trained epidemiologists.' They recognized the urgent need for a specialized team capable of rapidly identifying and responding to potential bioterrorism threats.
The new division soon evolved to address a wide range of civilian public health threats. In 1955, as one of its first major actions, the program's officers were tasked with investigating an outbreak of polio in children that started just as the first mass vaccination campaign against the disease launched. Within weeks, Epidemic Intelligence Service officers helped trace the outbreak to a few batches of a vaccine manufactured by a California company called Cutter Laboratories in which the virus had not been properly killed. The incident led to increased safety regulations in vaccine production and boosted public confidence, paving the way to eliminating polio from the U.S. in the ensuing decades.
The Epidemic Intelligence Service has led the way in tackling many of the most historically significant outbreaks of the past 75 years. Starting in 1966, the unit's officers were deployed to West Africa to assist in a worldwide smallpox eradication campaign that laid the groundwork for eliminating the disease 13 years later. In 1976, the disease detectives were sent to investigate an outbreak in Philadelphia of a mysterious deadly illness. They helped to characterize what would eventually be known as Legionnaires' disease, a previously unknown bacterial cause of pneumonia.
And in 1981, a tip from an Epidemic Intelligence Service officer serving in the Los Angeles County Health Department led to the first description of a new disease that would become the global epidemic of HIV-AIDS. The program's officers went on to help lead foundational studies on prevalence, prevention and treatment of AIDS around the world.
Even from its earliest days, vaccine-preventable and infectious diseases were far from the Epidemic Intelligence Service's only focus. During the program's first 15 years, its officers were involved in a wide swath of epidemiological investigations in areas including lead paint exposure, a cancer cluster's connection to birth defects, family planning practices and famine relief.
These activities established the group's priorities of addressing chronic diseases and population health – goals that have also driven its involvement in disaster response efforts, including hurricanes Harvey, Irma, Maria and Katrina, as well as the terrorist attacks on Sept. 11, 2001.
The Epidemic Intelligence Service has also played a key role in keeping the nation's food supply safe. It investigates major outbreaks of foodborne illnesses, helping to identify which foods are implicated so that contaminated products are removed from shelves and disseminating investigation findings that inform food safety policy. For example, officers investigated a 1993 outbreak of Escherichia coli O157:H7 linked to undercooked hamburgers at several Jack in the Box restaurants. The outbreak sickened more than 700 people and resulted in the deaths of four children. It also led to major food safety reforms including expanded meat and poultry inspection nationwide.
The importance of an expert, nimble team of disease detectives has only increased. Over the past few years, Epidemic Intelligence Service officers have responded to countless public health threats.
The program's officers were involved at every stage of the COVID-19 pandemic response, conducting outbreak investigations on cruise ships, in prisons and in many other settings. They investigated the outbreak of monkeypox in the U.S. in 2022. Most recently they have investigated cases of avian influenza and are working to help describe and control the ongoing measles outbreak in Texas.
Perhaps the Epidemic Intelligence Service's most significant legacy has been in building a worldwide network of deep epidemiological expertise. To date, the program has trained more than 4,000 disease detectives, and its officers have collectively conducted thousands of outbreak investigations.
The unit's impact has been global. It has been called in to investigate outbreaks on six continents and has served as a model for epidemiology programs developed in dozens of countries.
All of these activities, at home and abroad, have shaped health policy in crucial ways that in turn protect people's health. It is increasingly clear that disease outbreaks will continue to occur in the U.S. and abroad. In our view, the Epidemic Intelligence Service's history provides rich evidence of its value.
This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Mark Dworkin, University of Illinois Chicago and Casey Luc, University of Illinois Chicago
Read more:
CDC layoffs strike deeply at its ability to respond to the current flu, norovirus and measles outbreaks and other public health emergencies
Susan Monarez, Trump's nominee for CDC director, faces an unprecedented and tumultuous era at the agency
How big will the coronavirus epidemic be? An epidemiologist updates his concerns
I am currently a member of the EIS Alumni Association Executive Committee.
Casey Luc does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
A new COVID variant known as NB.1.8.1 has made landfall in the United States. The variant, which was first detected in China this past January, currently accounts for 10% of the SARS-CoV-2 sequences tested from around the world, recent surveillance data found. That's a significant jump from 2.5% four weeks ago. A Centers for Disease Control and Prevention (CDC) spokesperson told HuffPost that the agency is in regular contact with international partners about the activity of NB.1.8.1. To date, only 20 NB.1.8.1 sequences have been identified in the U.S. — that's below the threshold needed for a variant to appear on the agency's COVID dashboard. (As soon as its prevalence increases, NB.1.8.1 will pop up on the tracker, the spokesperson added.) It's nerve-wracking to hear that a new variant is making the rounds, but infectious disease specialists say there are no glaring differences between the symptoms of NB.1.8.1 and those caused by other versions of SARS-CoV-2. 'Currently it appears that NB.1.8.1 would have similar symptoms to other COVID variants that have recently been circulating,' Dr. Zachary Hoy, a pediatric infectious disease specialist with Pediatrix Medical Group in Nashville, Tennessee, told HuffPost. Here's what to know about the newest COVID variant that's gaining traction around the world. Compared to the currently dominant variant in the U.S. (LP.8.1), NB.1.8.1 has a handful of new mutations on the spike protein that may enhance its ability to bind to our cells, according to the World Health Organization (WHO). The agency suspects these mutations will increase the virus's transmissibility and, potentially, diminish the effectiveness of neutralizing antibodies that prevent pathogens from latching to our cells. In other words, the variant may be skilled at dodging some of our immune defenses, research suggests. According to Dr. Amesh Adalja, an infectious diseases expert and senior scholar at the Johns Hopkins University Center for Health Security, NB.1.8.1's symptoms are pretty much the same as those seen with other SARS-CoV-2 variants. Two of COVID's hallmark symptoms are a mild but persistent dry cough and nasal congestion, Hoy said. Many people who come down with COVID are also hit with fatigue and tiredness. 'An infected person can still make it through the day, but they are resting more and feel more tired throughout the day,' Hoy said. Other common symptoms include a fever, chills, a sore throat and muscle aches. 'Some have described recent variants as less intense symptoms as compared to wintertime influenza viruses, but both can have severe symptoms,' Hoy said. There's no evidence suggesting the variant causes more severe disease or an uptick in hospitalizations or deaths, the WHO states. The only noticeable aspect, as of now, is that it's rising in prevalence, Adalja said. It's too early to know exactly how effective the shots are — as the research on NB.1.8.1 is limited since it's so new — but scientists expect the shots to hold up well. NB.1.8.1 broke off from the Omicron JN.1 lineage, which the 2024-2025 vaccines target. 'The ability of the vaccines to prevent severe illness is intact though protection versus infection is limited and transient,' Adalja said. Anyone who is at risk of severe disease should stay up-to-date with the shots. 'Those in older populations or with underlying immune disorders or on immune-decreasing medications would benefit more from vaccination or those with increased exposure such as healthcare workers,' Hoy added. So if you have a condition that puts you at risk, it's worth getting vaccinated if it's been more than six months since your last vaccine or bout of COVID, Adalja advises. He also added that those who are low-risk likely do not need to go out and get another shot. Most people will be able to recover at home by resting and staying hydrated. While you're sick, acetaminophen and ibuprofen can help alleviate muscle aches and fevers, Hoy said. And, in most cases, symptoms should clear up within a week. For those who are at risk for severe disease, including older adults and people who are immune-compromised, it's worth contacting a physician as they can prescribe antivirals — Paxlovid and Molnupiravir — that can significantly lower the risk of severe complications and death. As was the case with previous variants, these antivirals work best when started within five days of symptom onset. As for when you should go to an urgent care or emergency room? When you have chest pain, have a hard time waking up or staying awake, or feel confused and disoriented, the CDC advises. Hoy says the most concerning symptom he warns patients about is difficulty breathing. 'If you have COVID or COVID-like illness and have worsening trouble breathing or chest pain, you should be evaluated at your doctor's office, urgent care or the ER,' he said. RFK Jr. Says COVID Shot Will No Longer Be Advised For Healthy Kids, Pregnant Women Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried New Trump Vaccine Policy Limits Access To COVID Shots


The Hill
34 minutes ago
- The Hill
Beyond MAHA: Defeating obesity requires a new strategy
Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.
Yahoo
2 hours ago
- Yahoo
GOP's health care plan: We're all going to die, so whatever
If death and taxes are the only certainties, Joni Ernst is here to cut one and fast-track the other. 'We all are going to die," she said. You might think that's a line from a nihilistic French play. Or something a teenage goth said in Hot Topic. Or an epiphany from your stoner college roommate after he watched Interstellar at 3 a.m. But that was actually the Iowa Senator's God-honest response to concerns that slashing Medicaid to achieve President Trump's 'Big Beautiful Bill' would lead to more preventable deaths. The full exchange at a May 30 town hall included one audience member shouting at the stage, 'People will die!' And Ernst responding, 'People are not — well, we all are going to die, so for heaven's sake.' That's not a health care policy — that's a horoscope for the terminally screwed. As you can imagine, the internet didn't love it, because losing your health should not trigger the equivalent of a shrug emoji from someone elected to serve the public good. But rather than walking it back, Ernst leaned in, filming a mock apology in a graveyard because nothing says, 'I care about your future,' like filming next to people who don't have one. Opinion: Nurses are drowning while Braun ignores Indiana's health care crisis Ernst's comments aren't just philosophical musings. She's justifying policy choices that cause real harm. If passed, this bill would, according to the Congressional Budget Office, remove health coverage for up to 7.6 million Americans. That's not just 'we all die someday' territory. That's 'some people will die soon and needlessly.' What makes this even more galling is that the people pushing these cuts have access to high-quality, taxpayer-subsidized healthcare. Congress gets the AAA, platinum, concierge-level government plan. Meanwhile, millions of Americans are told to try their luck with essential oils or YouTube acupuncture tutorials. Honestly, it felt more like performance art than policy: 'Sorry about your grandma getting kicked out of her assisted living facility. Please enjoy this scenic view of her future! LOL!' We're not asking you to defeat death, senator. Death is both inevitable and bipartisan. But there is a broad chasm between dying peacefully at 85 and dying in your 40's because your Medicaid plan disappeared and your GoFundMe didn't meet its goal. Fundamentally, governing is about priorities. A budget is a moral document. When a lawmaker tells you 'we're all going to die' in response to a policy choice, they're telling you 'I've made peace with your suffering as collateral damage.' And if a U.S. Senator can stand in a cemetery and joke about it, you have to wonder — who do our federal legislators think those graves are for? Opinion: Indiana DCS cut foster care in half — and now claims children are safer This isn't just about one comment or one bill. It's about a mindset that treats healthcare as a luxury rather than a right. If death is inevitable, then access to healthcare you can afford is what helps determine how long you have, how comfortably you live, and whether you get to watch your kids grow up. Healthcare isn't about escaping death. It's about dignity and quality of life while we are here. Ernst got one thing right: death will come for us all. But leadership, real leadership, is about helping people live as long and as well as they can before that day comes. You want to make jokes, Senator? Fine. But if your punchline is 'You're all going to die anyway,' don't be surprised when your constituents realize the joke's on them. Kristin Brey is the "My Take" columnist for the Milwaukee Journal Sentinel. This article originally appeared on Milwaukee Journal Sentinel: Joni Ernst films graveyard video after telling sick people "we all die" | Opinion